Dr Reddys Laboratories (RDY) Tax Provisions (2012 - 2026)

Dr Reddys Laboratories' Tax Provisions history runs 15 years deep, the most recent figure standing at -$2.3 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 104.85% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at $142.0 million (down 38.65% YoY), while the FY2026 annual figure was $132.0 million, down 42.36% from the prior year.
• Tax Provisions was -$2.3 million for Q1 2026 at Dr Reddys Laboratories, down from $39.7 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $68.7 million in Q3 2024 to a low of -$2.3 million in Q1 2026.
• Historically, Tax Provisions has averaged $45.2 million across 5 years, with a median of $52.4 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Tax Provisions soared 111549560.24% in 2023, then plunged 104.85% in 2026.
• A 5-year view of Tax Provisions shows it stood at $45.0 million in 2022, then advanced by 19.24% to $53.7 million in 2023, then advanced by 3.83% to $55.7 million in 2024, then decreased by 28.79% to $39.7 million in 2025, then plunged by 105.9% to -$2.3 million in 2026.
• The last three Tax Provisions figures came in at -$2.3 million (Q1 2026), $39.7 million (Q4 2025), and $46.8 million (Q3 2025), per Business Quant data.